Drug Discovery World

JULY 20, 2023

Chemspace’s compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for assay development, contract screening and contract array manufacturing. SMMs enable high-throughput screening of compound libraries against targets of interest. PROTAC), and training AI drug discovery models.

Compound Screening 40

Compound Screening RNA Development Protein 40

Drug Discovery World

OCTOBER 4, 2022

William Erhardt , President, Head of Development & Operations of biotech Oligomerix, tells Lu Rahman about the company’s differentiated approach to developing disease-modifying therapeutics for neurodegenerative diseases. . Overcoming sector challenges . Furthermore, the global need is about seven times greater than the US.

Development 52

Development In-Vivo Compound Screening Clinical Development 52

Drug Discovery World

JANUARY 26, 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

Drug Discovery World

FEBRUARY 22, 2024

Libra Therapeutics is a San Diego-based biotech focused on developing novel disease-modifying therapeutics, which restore the cellular balance that is disrupted in neurodegenerative diseases. Libra is a completely virtual company, based on a “plug and play concept and mode of operation”, Gill explains.

Clinical Trials 52

Clinical Trials Clinical Trials Trials In-Vivo 52

Drug Discovery World

JANUARY 23, 2023

We witnessed the unprecedented pace of vaccine development, fuelled by cutting-edge mRNA technology. But along with this massive disruption came an opportunity: to apply our platform to researching the SARS-CoV-2 virus. In an emerging public health crisis, time is of the essence.

Drugs 59

Drugs Clinical Trials Clinical Trials Compound Screening 59

Drug Discovery World

AUGUST 15, 2023

Although such electrophysiological systems may be more predictive of potential cardiac safety and efficacy than non-functional binding assays, many apparently attractive new drugs are still being discontinued later in development. Unexpected late-stage failures in drug development are, of course, the costliest.

Drugs 52

Drugs In-Vivo Development Research 52